Skip to main content
Past Event

Rebuilding the US medical supply chain

Past Event

In the race to end the COVID-19 pandemic, the world saw an unprecedented process to quickly research, develop, test, and deploy a vaccine to protect against the virus. But like many other facets of life, the pandemic also exposed, and in some cases exacerbated, problems in drug and medical supply manufacturing. Global supply chains were disrupted leading to shortages of medicines and personal protective equipment. Many health care systems around the country were overwhelmed with sick patients, calling into question the ability to provide quality health care to Americans.

On June 11, Governance Studies at Brookings and the Olin Business School at Washington University in St. Louis cohosted a webinar to discuss pharmaceutical drug manufacturing and supply chain logistics in the aftermath of the COVID-19 pandemic. Panelists unpacked current obstacles in manufacturing drugs and medical supplies in the United States and solutions to those barriers.

Viewers submitted questions for speakers by emailing or via Twitter at @BrookingsGov by using #USSupplyChain.



Edward Price


Former President and CEO - PCI Synthesis

Tony Sardella

Adjunct Professor and Senior Research Advisor, Olin School of Business and Center for Analytics and Business Insights - Washington University in St. Louis

David H. Thompson

Co-Founder & Chief Technology Officer - Continuity Pharma

Professor of Chemistry - Purdue University

More Information

To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.

Get a weekly events calendar from Brookings